1. Regression of uterine cervical diffuse large B-cell lymphoma transformed from mucosa-associated lymphoid tissue lymphoma subsequent to Chlamydia trachomatis eradication.
- Author
-
Mutoh T, Takatsuki H, Mannoji K, Kawamura K, Okura N, and Ohshima K
- Subjects
- Adult, Chlamydia Infections drug therapy, Female, Humans, Treatment Outcome, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms virology, Chlamydia Infections complications, Chlamydia trachomatis drug effects, Lymphoma, B-Cell, Marginal Zone drug therapy, Lymphoma, B-Cell, Marginal Zone virology, Lymphoma, Large B-Cell, Diffuse drug therapy, Uterine Cervical Neoplasms drug therapy
- Abstract
A 37-year-old-woman was referred to our center after her uterine cervix health screening presented abnormal findings. We performed a biopsy of the uterine cervix to examine for cervical dysplasia, and diagnosed a diffuse large B-cell lymphoma transformed from mucosa-associated lymphoid tissue (MALT) lymphoma of the cervix. The patient presented with concurrent chlamydial cervicitis and received eradication therapy for Chlamydia trachomatis. Four months later, the CD20 positive abnormal lymphocyte disappeared and complete remission was achieved. MALT lymphoma is considered to correlate with infection and inflammation. Particularly, the relationship between gastric MALT lymphoma and Helicobacter pylori is well known. MALT lymphoma of the uterine cervix is rare, and its relationship with C.trachomatis infection is unknown. Further studies are warranted to investigate this association.
- Published
- 2017
- Full Text
- View/download PDF